Finding 1
insufficientThe alpha-bisabolol literature is dominated by laboratory, animal, and non-cannabis formulation research.
Limit: A broad preclinical review does not establish efficacy in cannabis consumers.
A chamomile-like sesquiterpene alcohol with mostly preclinical evidence.
Identity and cannabis context
Alpha-bisabolol is a minor analyte included on some regulated cannabis panels.
People commonly describe isolated alpha-bisabolol with floral, chamomile, sweet notes. A finished flower or extract contains a more complex volatile mixture.
Evidence insufficient
Reviews summarize laboratory and animal research across several models.
The alpha-bisabolol literature is dominated by laboratory, animal, and non-cannabis formulation research.
Limit: A broad preclinical review does not establish efficacy in cannabis consumers.
Clinical cannabis studies have not shown pain, inflammation, anxiety, or skin benefits at product-level exposure.
A certificate of analysis identifies composition, not a safe or effective dose. Inhalation can irritate airways, and heating terpenes can create degradation products.
This page is educational and does not provide medical advice. Route, dose, oxidation, heat, other ingredients, and individual health conditions all change risk.
This bounded preview shows records whose available profile contains Alpha-Bisabolol. It is not a total, a dominant-terpene ranking, or a guarantee about a current retail batch.
Life Sciences, 2022 • insufficient
New York State Office of Cannabis Management, 2026 • chemistry
Older deep dive: Alpha-Bisabolol article. This profile is the current evidence summary.
Alpha-Bisabolol (α-Bisabolol) is a chamomile-like sesquiterpene alcohol with mostly preclinical evidence. Alpha-bisabolol is a minor analyte included on some regulated cannabis panels.
Common descriptors include floral, chamomile, sweet. Aroma is subjective, and other volatile compounds in the tested product also matter.
Reviews summarize laboratory and animal research across several models. Clinical cannabis studies have not shown pain, inflammation, anxiety, or skin benefits at product-level exposure.
No. A lab result identifies chemistry in one sample. It does not guarantee a feeling, benefit, dose, or response for an individual consumer.
Compare all 26 profiles, their aliases, and their evidence limits.
Browse all terpene profiles